In the past decade, evidence for the numerous roles of copper (Cu) in mammalian
physiology has grown exponentially. The discoveries of Cu involvement in cell signaling …

Nonalcoholic steatohepatitis (NASH) is the advanced form of nonalcoholic fatty liver disease
(NAFLD). It is characterized by hepatic steatosis, inflammation, hepatocellular injury, and …

Thirty-five years ago, precision-cut liver slices (PCLS) were described as a promising tool
and were expected to become the standard in vitro model to study liver disease as they tick …

Non-alcoholic fatty liver disease (NAFLD), one of the most common types of chronic liver
disease, is strongly correlated with obesity, insulin resistance, metabolic syndrome, and …

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the definition recently
proposed to better circumscribe the spectrum of conditions long known as non-alcoholic fatty …

Vascular adhesion protein-1 (VAP-1) is a semicarbazide-sensitive amine oxidase (SSAO),
whose enzymatic activity regulates the adhesion/exudation of leukocytes in/from blood …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing healthcare
problem with limited therapeutic options. Progress in this field depends on the availability of …

Metabolic dysfunction-associated fatty liver disease (MASLD) presents a growing global
health challenge with limited therapeutic choices. This review delves into the array of ex vivo …

It is known that the inflammation process leading to oxidative stress and thyroid hormone
metabolism dysfunction is highly altered in metabolic dysfunction associated with steatotic …

ABSTRACT Vascular adhesion protein‐1 (VAP‐1) plays a dual role with its adhesive and
enzymatic properties, facilitating leukocyte migration to sites of inflammation and catalyzing …